The effect of ts-11 strain mycoplasma gallisepticum vaccination in commercial layers on egg production and selected egg quality parameters

Live Mycoplasma gallisepticum (MG) vaccines have been USDA approved and licensed for use in commercia layer chickens since 1988; however, egg production and egg quality data exist only for the F strain of MG. Information pertinent, to the effects of ts-11 MG on egg and eggshell quality parameters, as well as egg size distribution, is lacking. In this study, pullers were inoculated at 10 wk of age with ts-11 strain MG and placed in biological isolation units at 10 birds/unit. Hen-day egg production, eggshell strength, Haugh unit score, pimpling incidence, and blood/meat spot incidence were monitored and recorded in each trial through a 45-wk production cycle. Further, eggs from all treatments were collected daily Monday-Thursday, and individually weighed. Results of this study indicate that no significant difference was observed between the treatments for the parameters measured or for egg size distribution. Therefore, these data should lessen producers' concerns pertaining to the impact of ts-11 strain MG on egg production, egg and eggshell quality parameters, and egg size distribution.